Omen 13 An osteoarthritis gene-therapy candidate designed to reduce pain-associated inflammation, protect cartilage, and support cartilage-matrix production; currently in IND-enabling studies.
Visit productCosigns Received
Be the first Cosign
Put your name behind Omen 13.
Add it to your Products I use list and share why you use it.